Biontech

Covid-19 Vaccine 90% Effective In Phase 3 Trial, Says US Pharma Giant Pfizer

Coronavirus Vaccine | 'Robust Immunity' Induced By Pfizer-BioNTech Vaccine Candidate In Early-Phase Clinical Trial: Study